| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5700156 | Clinical Oncology | 2006 | 9 Pages |
Abstract
Although novel therapies may produce different toxicities, the current recommendations should help to produce trial protocols that will allow comparable data to be generated within clinical trials comparing outcome from surgery, radiotherapy and other targeted ablative therapies for EPC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
A. Henderson, H.J.N. Andreyev, R. Stephens, D. Dearnaley,